BREAKING NEWS

EU recommends suspending hundreds of drugs tested by Indian firm

By REUTERS

MARCH 25, 2017 12:29

Europe's medicines regulator has recommended the suspension of more than 300 generic drug approvals and drug applications due to "unreliable" tests conducted by Indian contract research firm Micro Therapeutic Research Labs.

The decision, announced by the European Medicines Agency (EMA) on its website, is the latest blow for India's drug-testing industry, which has run into a series of problems with international regulators in recent years.

Nobody at the Chennai-based company was immediately available to comment.

The EMA said European officials had been investigating Micro Therapeutic's compliance with good clinical practice after Austrian and Dutch authorities raised concerns in February 2016.

Philippines Marcos says threat of assassination 'troubling'

By REUTERS

11/25/2024 07:15 AM

Russia says it downs seven Ukrainian missiles over Kursk region

By REUTERS

11/25/2024 06:16 AM

Uruguay's center-left secures presidential victory with 49%

By REUTERS

11/25/2024 05:31 AM

Australia PM plays down privacy fears of social media ban for children

By REUTERS

11/25/2024 04:58 AM